Ignyta, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
Biotech Bounce “Ignyted” By Roche Deal
Article By: Rod Raynovich
Friday, December 22, 2017 3:07 PM EDT
Biotech stocks escaped the doldrums today ignited by Roche (RHHBY) acquisition of Ignyta, Inc. (RXDX) for $1.7B in an all-cash transaction.
In this article: RHHBY, RXDX Also: ARRY, IBB, CELG, EXEL, SAGE, GLYC, AGIO, TSRO, EDIT, BPMC
Read
These 5 Stocks Have Popped More Than 100% Since Trump's Win
Article By: Swarup Gupta
Wednesday, December 13, 2017 5:07 PM EDT
Following a particularly strong jobs report last week, President Trump once again took to Twitter to tout the economy’s stellar performance during his tenure.
In this article: SGMO, TREE, RH, RXDX, SEDG
Read
Ignyta Announces Pricing Of Public Offering Of Common Stock
Article By: Business Wire
Friday, October 20, 2017 2:00 AM EDT
Ignyta anticipates using the net proceeds from the offering to fund R&D activities for its development programs, including the clinical development and pre-commercialization activities of entrectinib, and ongoing development of other pipeline assets.
In this article: RXDX
Read
HH Small Cap Biotech Stocks Soar: How Long Will Rotation Last?
Article By: Rod Raynovich
Thursday, October 5, 2017 9:06 PM EDT
Speculation in small cap biotech picks up, a boon for diligent traders. ETF buying is driving all small cap and microcap stocks higher.
In this article: AVEO, ZIOP, IJS, IWC, IWM, XBI, FPRX, RXDX, XNCR, CNCR, EDIT
Read
4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings
Article By: Arpita Dutt
Monday, July 17, 2017 11:35 AM EDT
Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson reporting second quarter results tomorrow before the market opens.
In this article: VRX, FLXN, RXDX, ANIK Also: JNJ, NVS
Read

PARTNER HEADLINES

Latest Tweets for $RXDX

No tweets yet!